Portfoliotracker

Armata Pharmaceuticals, Inc.

ARMP · NYSE AMERICAN · Healthcare Biotechnology 0/100 E

2,990 $
▼ −0,880 (−22,74 %)
Pre-market
Price as of 16. 11. 22:00, fetched 17. 11. 13:37
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score0 / 100 Market cap187 mil. $ P/E– Forward P/E-1,5 P/S– P/B– EV/EBITDA– Dividend yield– FCF yield-14,33 % EPS-4,17 $ Net margin0,0 % Return on equity– Beta1,63 Debt / equity–
52-week range 2,75 to 14,98
3-month average volume0,2 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; and AP-PA03 for Pseudomonas aeruginosa. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

Employees
61
Country
United States
Fiscal year end
31. 12.
Data since
20. 5. 1994

Explore further

Similar companies TRVIKRSA

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account